CERUS CORP Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
CERUS CORP (CERS) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$162.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-30
- CERUS CORP effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was -$122.00K, a 165.59% decline year-over-year.
- CERUS CORP effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $186.00K.
- CERUS CORP effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$90.00K, a 177.59% decline year-over-year.
- CERUS CORP effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $116.00K.
- CERUS CORP effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $336.00K.
- CERUS CORP effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$191.00K.
- CERUS CORP effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was -$128.00K.
- CERUS CORP effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$727.00K.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$162.00K 10-Q · filed 2026-07-30 | |||
| 2026-03-31 | -$122.00K 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | $336.00K 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $336.00K 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $396.00K 10-Q · filed 2026-07-30 | |||
| 2025-03-31 | $186.00K 10-Q · filed 2026-04-30 | |||
| 2024-12-31 | -$191.00K 10-K · filed 2026-03-02 | |||
| 2024-09-30 | $46.00K 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$106.00K 10-Q · filed 2025-08-05 | |||
| 2024-03-31 | -$90.00K 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | -$128.00K 10-K · filed 2026-03-02 | |||
| 2023-09-30 | -$112.00K 10-Q · filed 2024-10-31 | |||
| 2023-06-30 | -$5.00K 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | $116.00K 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$727.00K 10-K · filed 2025-02-26 | |||
| 2022-09-30 | -$1.13M 10-Q · filed 2023-11-02 | |||
| 2022-06-30 | -$718.00K 10-Q · filed 2023-08-03 | |||
| 2022-03-31 | -$284.00K 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$919.00K 10-K · filed 2024-03-05 | |||
| 2021-09-30 | -$639.00K 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | -$363.00K 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | -$521.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $1.07M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $625.00K 10-Q · filed 2021-11-02 | |||
| 2020-06-30 | $115.00K 10-Q · filed 2021-08-03 | |||
| 2019-12-31 | -$339.00K 10-K · filed 2022-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |